877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Pyrimidines, Antineoplastic and immunomodulating drugs, Non-receptor tyrosine kinase inhibitors

Categories

Antineoplastic drugs (1)
Cyclic compounds (1)
Five-membered rings (1)
Imidazoles (1)
Pharmaceuticals (1)
Pyridines (1)
Six-membered rings (1)
Tyrosine kinase inhibitors (1)

Suppliers

AK Scientific (1)
Matrix Scientific (1)
Oakwood Chemical (1)
Toronto Research Chemicals (1)
Sigma Aldrich (1)

Nilotinib (641571-10-0)  
Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. Structurally related to imatinib, it was developed based on the structure of the Abl-imatinib complex to address imatinib intolerance and resistance. Nilotinib is a selective Bcr-Abl kinase inhibitor that is 10–30 fold more potent than imatinib in inhibiting Bcr-Abl tyrosine kinase activity and proliferation of Bcr-Abl expressing cells.
Related searches
Pyrimidines
Antineoplastic and immunomodulating drugs
Non-receptor tyrosine kinase inhibitors